Metastatic Colorectal Cancers Completed Phase 2 Trials for Sorafenib (DB00398)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01471353Sorafenib Plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal CancerTreatment
NCT00326495BAY 43-9006 Plus Cetuximab to Treat Colorectal CancerTreatment